Reexamining PGNMID: Heterogeneity and Implications for MGRS Classification
A recent cohort study challenges the traditional view of PGNMID as a monoclonal gammopathy. Findings suggest that the majority of PGNMID cases, especially those with IgG3 deposits, are oligoclonal or polyclonal, questioning their classification within MGRS.